Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Express Scripts
Accenture
Federal Trade Commission
Baxter
US Army
Farmers Insurance
Fish and Richardson
AstraZeneca
Cantor Fitzgerald

Generated: October 24, 2017

DrugPatentWatch Database Preview

CARBOCAINE Drug Profile

« Back to Dashboard

What is the patent landscape for Carbocaine, and what generic Carbocaine alternatives are available?

Carbocaine is a drug marketed by Eastman Kodak and Hospira and is included in two NDAs.

The generic ingredient in CARBOCAINE is levonordefrin; mepivacaine hydrochloride. There are two drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the levonordefrin; mepivacaine hydrochloride profile page.

Summary for Tradename: CARBOCAINE

US Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list1
Bulk Api Vendors: see list45
Clinical Trials: see list3
Patent Applications: see list518
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CARBOCAINE at DailyMed

Pharmacology for Tradename: CARBOCAINE

Ingredient-typeAmides
Drug ClassAmide Local Anesthetic
Physiological EffectLocal Anesthesia
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Eastman Kodak
CARBOCAINE
mepivacaine hydrochloride
INJECTABLE;INJECTION012125-003Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Hospira
CARBOCAINE
mepivacaine hydrochloride
INJECTABLE;INJECTION012250-002Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe
Hospira
CARBOCAINE
mepivacaine hydrochloride
INJECTABLE;INJECTION012250-001Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe
Hospira
CARBOCAINE
mepivacaine hydrochloride
INJECTABLE;INJECTION012250-005Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe
Eastman Kodak
CARBOCAINE W/ NEO-COBEFRIN
levonordefrin; mepivacaine hydrochloride
INJECTABLE;INJECTION012125-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
US Army
Queensland Health
Cerilliant
Argus Health
Federal Trade Commission
Johnson and Johnson
Chubb
AstraZeneca
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot